|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/26 | (2006.01) |
| C07K 16/26 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/2803 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K2039/507 | (2013.01) | ||
| C07K2317/565 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61K2039/505 | (2013.01) |
| (11) | Patento numeris | 3720879 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18829742.8 |
| Europos patento paraiškos padavimo data | 2018-12-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-10-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-05-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2018/083651 |
| Data | 2018-12-05 |
| (87) | Numeris | WO 2019/110662 |
| Data | 2019-06-13 |
| (30) | Numeris | Data | Šalis |
| 201762594755 P | 2017-12-05 | US |
| (72) |
PRIEUR, Alexandre , FR
|
| (73) |
Progastrine et Cancers S.à r.l. ,
11, Côte d'Eich, 1450 Luxembourg,
LU
|
| (54) | COMBINATION THERAPY BETWEEN ANTI-PROGASTRIN ANTIBODY AND IMMUNOTHERAPY TO TREAT CANCER |
| COMBINATION THERAPY BETWEEN ANTI-PROGASTRIN ANTIBODY AND IMMUNOTHERAPY TO TREAT CANCER |